During the Trading Day
|1.63|| +0.09 / +5.84%|
As of 3:59pm ET
|1.65|| +0.02 / +1.23%|
Aevi Genomic Medicine, Inc. is a medical technology company, which focuses on finding treatments for rare and orphan diseases, with a particular focus on pediatrics, following a genomics medicine strategy. Its Transduced Autologous Restorative Gene Therapy platform is designed to provide sustained protein and peptide therapies to treat a range of chronic diseases and conditions. The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.
|Michael F. Cola||President, Chief Executive Officer & Director|
|Brian D. Piper||Chief Financial & Principal Accounting Officer|
|Garry Arthur Neil||Chief Scientific Officer|